{"id":42816,"date":"2015-10-01T00:00:00","date_gmt":"2015-09-30T22:00:00","guid":{"rendered":"https:\/\/techma.bakertilly.es\/las-biotecnologicas-espanolas-se-internacionalizan-artax-biopharma-pharmamar-mind-byte\/"},"modified":"2025-03-12T11:35:46","modified_gmt":"2025-03-12T10:35:46","slug":"las-biotecnologicas-espanolas-se-internacionalizan-artax-biopharma-pharmamar-mind-byte","status":"publish","type":"post","link":"https:\/\/techma.bakertilly.es\/en\/las-biotecnologicas-espanolas-se-internacionalizan-artax-biopharma-pharmamar-mind-byte\/","title":{"rendered":"Spanish biotech companies internationalise: Artax Biopharma, PharmaMar and Mind The Byte"},"content":{"rendered":"<address><span style=\"color: #000000;\">In the last month we have seen how Spanish biotech companies are growing and opening up to new markets. Artax Biopharma has just received $10M from American investors, PharmaMar has started selling its product in Japan and Mind The Byte has just opened a subsidiary in Copehenague.<\/span><!--more--><\/address>\n<p><a href=\"https:\/\/techma.bakertilly.es\/wp-content\/uploads\/2020\/09\/biotec.jpg\"><img decoding=\"async\" class=\"aligncenter wp-image-6589 size-full\" src=\"https:\/\/techma.bakertilly.es\/wp-content\/uploads\/2020\/09\/biotec.jpg\" alt=\"biotec\" width=\"1040\" height=\"720\" title=\"\"><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"color: #3366ff;\"><strong>Spain's Artax Biopharma raises $10M in funding<\/strong><\/span><\/p>\n<p><span style=\"color: #000000;\"><span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.artaxbiopharma.com\/\" target=\"_blank\" rel=\"noopener\">Artax Biopharma<\/a><\/span> is a Spanish startup that, after only two years of life, has received an injection of $10M in funding.<\/span><\/p>\n<p><span style=\"color: #000000;\">Artax is studying drugs that block a protein called NCK to stop lymphocytes from attacking healthy tissues.<\/span><\/p>\n<p><span style=\"color: #000000;\">This young startup has a staff of only 4 employees but this has not prevented them from attracting the attention of foreign investors. The round has been led by Henri Termeer<strong>, <\/strong>CEO of Genzyme and the European fund Advent Life Sciences and other individual investors have also participated.<\/span><\/p>\n<p><span style=\"color: #000000;\">Artax Biopharma has offices in Valencia and Cambridge.<\/span><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><span style=\"color: #3366ff;\"><strong>PharmaMar consolidates its internalisation<\/strong><\/span><\/p>\n<p><span style=\"color: #000000;\"><span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.pharmamar.com\/\" target=\"_blank\" rel=\"noopener\">PharmaMar<\/a><\/span> announced this week that its partner in Japan, Taiho Pharmaceutical, has received approval from the Japanese Ministry of Health to market its drug Yondelis for the treatment of patients with soft tissue sarcoma.<\/span><\/p>\n<p><span style=\"color: #000000;\">In mid-September, PharmaMar opened a subsidiary in London, strengthening its business in Europe after Italy, Germany, France, Switzerland and Spain, where it is headquartered.<\/span><\/p>\n<p><span style=\"color: #000000;\">PharmaMar also plans to enter the US market at the end of this year and to go public in the US by mid-2016.<\/span><\/p>\n<p><span style=\"color: #000000;\">\"PharmaMar, which started out as Zeltia's oncology division, specialising in the development of drugs with molecules extracted from the seabed, has been growing and becoming the jewel in Zeltia's crown. So much so that in June 2015 the merger of Zeltia with the oncology subsidiary was approved and Pharmamar took the lead of the group. What started out as a risky investment with more hope than ambition has become a success, and with only one drug on the market, the anti-tumour drug Yondelis, PharmaMar contributes 90 % of the company's value\", says Diego Gutierrez of<span style=\"text-decoration: underline;\"><a href=\"https:\/\/techma.bakertilly.es\/en\/\"> Abra-invest<\/a><\/span><\/span><\/p>\n<p><span style=\"color: #3366ff;\"><strong>Mind The Byte raises round of funding<\/strong><\/span><\/p>\n<p><span style=\"color: #000000;\">La barcelonesa <span style=\"text-decoration: underline;\">\u00a0<span style=\"color: #000000; text-decoration: underline;\">Mind the Byte<\/span><\/span>\u00a0specialising in services for computational drug design, has presented at the PCB a campaign of<em>\u00a0<\/em><em>crowdfunding<\/em>\u00a0100,000 managed by\u00a0<a href=\"https:\/\/www.crowdcube.com\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000;\">Crowdcube<\/span><\/a> with the aim of boosting the international marketing of its services and products.\u00a0<em>cloud<\/em>\u00a0for computational drug design in SaaS mode.<\/span><\/p>\n<p><span style=\"color: #000000;\">This transaction is the company's second capital increase in less than a year, as at the end of 2014 it closed a \u20ac200,000 round led by<span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.inkemia.com\/\" target=\"_blank\" rel=\"noopener\">\u00a0<span style=\"color: #000000; text-decoration: underline;\">InKemia<\/span>.<\/a><\/span><\/span><\/p>\n<p><span style=\"color: #000000;\"><span style=\"text-decoration: underline;\"><a href=\"https:\/\/www.mindthebyte.com\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000; text-decoration: underline;\">Mind the Byte<\/span><\/a> <\/span>has just opened a subsidiary in the Copenhagen Bio Science Park (<a href=\"http:\/\/www.swedishlifesciences.se\/copenhagen-bio-science-park\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000;\">COBIS<\/span><\/a>), as the first step in a process of international expansion that the company will\u00a0<em>start-up<\/em>\u00a0has just started with the help of<span style=\"text-decoration: underline;\"> <a href=\"http:\/\/accio.gencat.cat\/cat\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000; text-decoration: underline;\">ACCI\u00d3<\/span><\/a>.<\/span><\/span><\/p>\n<p><span style=\"color: #000000;\">If you want to get both public and private funding, please contact us. Abra-Invest has a team of experts in alternative financing at your disposal. Call us at +34 946424142 or fill out the contact form\u00a0 \u00a0<\/span><\/p>\n<p><strong><span style=\"color: #3366ff;\">Other posts that may interest you<\/span><\/strong><\/p>\n<p><span style=\"text-decoration: underline;\"><a href=\"https:\/\/techma.bakertilly.es\/en\/novedades-inversion-biotecnologia-septiembre-2015\/\">Biotech investment news September 2015: CaixaIpulse, Sanifit and Centauri<\/a><\/span><\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>In the last month we have seen how Spanish biotech companies are growing and opening up to new markets. Artax Biopharma has just received $10M from American investors, PharmaMar has started selling its product in Japan and Mind The Byte has just opened a subsidiary in Copehenague.<\/p>","protected":false},"author":4,"featured_media":46380,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1750],"tags":[238,392],"sectores":[],"tipo-contenido":[2260],"class_list":["post-42816","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-financiacion-sectorial","tag-biotecnologia","tag-empresas-en-expansion","tipo-contenido-noticias"],"acf":[],"_links":{"self":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/42816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/comments?post=42816"}],"version-history":[{"count":0,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/42816\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/media\/46380"}],"wp:attachment":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/media?parent=42816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/categories?post=42816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tags?post=42816"},{"taxonomy":"sectores","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/sectores?post=42816"},{"taxonomy":"tipo-contenido","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tipo-contenido?post=42816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}